OrphanDrug
OrphanDrug
Pharma Knowledge Base

apparent mineralocorticoid excess syndrome

MeSH: D043204ORPHA: 320

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

Human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with apparent mineralocorticoid excess syndrome, sourced from HPO and Orphanet clinical annotations.

HypertensionHypokalemiaDecreased circulating renin concentrationNephrocalcinosisFailure to thrivePolydipsiaHypokalemic metabolic alkalosisDecreased circulating aldosterone concentrationShort statureAbnormality of circulating cortisol levelAbnormal urine sodium concentrationRenal insufficiencyHypertensive retinopathyStrokeIntrauterine growth retardationLeft ventricular hypertrophy

Classification & Codes

MeSH Code

D043204

Orphanet Code

ORPHA:320
apparent mineralocorticoid excess syndrome
MeSHD043204
OrphanetORPHA:320
Treatments0 drug(s)
Symptoms on record16 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO